cmi_logo.png
[Latest] Global Tourism Market Size/Share Worth USD 12,313.5 Billion by 2032 at a 3.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
February 01, 2024 11:30 ET | Custom Market Insights
Austin, TX, USA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Tourism Market Size, Trends and Insights By Travel Purpose (Leisure Tourism,...
Biocartis Group NV logo.png
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)
January 10, 2024 17:00 ET | Biocartis Group NV
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency notification (Article 14, first paragraph, of the...
Biocartis Group NV logo.png
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)
January 10, 2024 17:00 ET | Biocartis Group NV
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency notification (Article 14, first paragraph, of the Act of...
BC-LOGO 137542-1000x1000.jpg
Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion
November 22, 2023 04:00 ET | Biocartis NV
PRESS RELEASE - 22 November 2023, 10:00 CET BIOCARTIS HOLDINGS INC. RECAPITALIZATION COMPLETED AND PRODUCT PORTFOLIO EXPANSION The recapitalization of Biocartis was completed last week,...
BC-LOGO 137542-1000x1000.jpg
Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting
November 13, 2023 01:00 ET | Biocartis NV
PRESS RELEASE - 13 November 2023, 07:00 CET Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting Mechelen, Belgium and Itasca (IL),...
Persbericht Biocartis Group NV: Mededeling betreffende uitwinning door gewaarborgde schuldeisers
October 31, 2023 10:55 ET | Biocartis NV
PERSBERICHT - GEREGULEERDE INFORMATIE - 31 oktober 2023, 15:30 CET MEDEDELING BETREFFENDE UITWINNING DOOR GEWAARBORGDE SCHULDEISERS De Secured Creditors van de onderneming hebben hun zekerheid op de...
Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors
October 31, 2023 10:55 ET | Biocartis NV
PRESS RELEASE REGULATED INFORMATION 31 October 2023, 15:30 CET ANNOUNCEMENT REGARDING ENFORCEMENT BY SECURED CREDITORS The Company’s Secured Creditors have enforced their security over the shares of...
TIP_link_300x300.jpg
Point of Care Molecular Diagnostics Market Worth $5.38 Billion by 2028 - Exclusive Report by The Insight Partners
October 30, 2023 05:27 ET | The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as...
Persbericht Biocarti
Persbericht Biocartis Group NV: Vier abstracts, die uitstekende resultaten voor Idylla™ tonen, worden gepresenteerd op het European Society of Molecular Oncology (ESMO) congres
October 20, 2023 01:00 ET | Biocartis NV
PERSBERICHT 20 oktober 2023, 7:00 CEST Vier abstracts, die uitstekende resultaten voor Idylla™ tonen, worden gepresenteerd op het European Society of Molecular Oncology (ESMO) congres Mechelen,...
Press release Biocar
Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)
October 20, 2023 01:00 ET | Biocartis NV
PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO) Mechelen, Belgium, 20 October 2023 –...